SS
Satpal Singh
About Satpal Singh
Data last updated:
Satpal Singh is a Director at Asian Oncocare Private Limited (since 2022) and Designated Partner at Global Oncocare Hospital & Research Centre Llp (since 2017). The companies operate in Healthcare and Pharma. The largest current company by reported revenue is Asian Oncocare Private Limited at ₹1.61 Cr (FY 2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 May 2022 | 2014 | ₹1.61 Cr (FY 2016) | Active | |
| Designated Partner | 10 Jul 2017 | 2017 | Active |
Board colleagues of Satpal Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kailashwanti | 06921487 | Asian Oncocare Private Limited , Global Oncocare Hospital & Research Centre Llp | Director |
| Shayna Monga | 08211741 | Global Oncocare Hospital & Research Centre Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satpal Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satpal Singh
Satpal Singh currently holds 2 directorships: Asian Oncocare Private Limited (Director, since 30 May 2022, revenue ₹1.61 Cr (FY 2016)); Global Oncocare Hospital & Research Centre Llp (Designated Partner, since 10 Jul 2017).
Satpal Singh was first appointed on 10 Jul 2017 as Designated Partner at Global Oncocare Hospital & Research Centre Llp. The most recent appointment on record is 30 May 2022 at Asian Oncocare Private Limited.
The current boards of Satpal Singh's companies include Kailashwanti (Asian Oncocare Private Limited), Shayna Monga (Global Oncocare Hospital & Research Centre Llp).